{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:46:31Z","timestamp":1784609191486,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012465","name":"Dalian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cca.2025.120218","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:06:51Z","timestamp":1741000011000},"page":"120218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The establishment of specific reference intervals for serum transthyretin tetramer, misfolded proteins, and protein misfolding rate and its application in evaluating transthyretin amyloidosis patients"],"prefix":"10.1016","volume":"571","author":[{"given":"Tingting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-5765","authenticated-orcid":false,"given":"Yunfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120218_b0005","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41587-024-02471-1","article-title":"Amyloid is everywhere, but new treatments could stop the toxic build up","volume":"42","author":"Sheridan","year":"2024","journal-title":"Nat Biotechnol."},{"key":"10.1016\/j.cca.2025.120218_b0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","article-title":"Transthyretin-related amyloidoses and the heart: a clinical overview","volume":"7","author":"Rapezzi","year":"2010","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.cca.2025.120218_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.cca.2025.120218_b0020","doi-asserted-by":"crossref","first-page":"13158","DOI":"10.3390\/ijms222313158","article-title":"A brief journey through protein misfolding in transthyretin amyloidosis (ATTR Amyloidosis)","volume":"22","author":"Gonzalez-Duarte","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.cca.2025.120218_b0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10741-021-10080-2","article-title":"Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness","volume":"27","author":"Nativi-Nicolau","year":"2022","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.cca.2025.120218_b0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1262","article-title":"World heart federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)","volume":"18","author":"Brito","year":"2023","journal-title":"Glob Heart. Glob Heart."},{"key":"10.1016\/j.cca.2025.120218_b0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/14737167.2021.1900738","article-title":"Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain","volume":"21","author":"Galan","year":"2021","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.cca.2025.120218_b0040","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/cdd.2016.64","article-title":"Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia","volume":"23","author":"Gomes","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cca.2025.120218_b0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13195-021-00883-8","article-title":"Neuroprotection in early stages of Alzheimer's disease is promoted by transthyretin angiogenic properties","volume":"13","author":"Gi\u00e3o","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.cca.2025.120218_b0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc12-0455","article-title":"Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes","volume":"35","author":"Henze","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2025.120218_b0055","first-page":"394","article-title":"Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis","volume":"31","author":"Ni","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.cca.2025.120218_b0060","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.12659\/MSM.902348","article-title":"Association of serum prealbumin with angiographic severity in patients with acute coronary syndrome","volume":"23","author":"Zhang","year":"2017","journal-title":"Med Sci Monit."},{"key":"10.1016\/j.cca.2025.120218_b0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028534","article-title":"Design and rationale the SCAN-MP (Screening for cardiac amyloidosis with nuclear imaging in minority populations) study","volume":"12","author":"Ruberg","year":"2023","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.cca.2025.120218_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117709","article-title":"An ultra performance liquid chromatography method for transthyretin variants screening and heart failure assisting diagnosis","volume":"553","author":"Wang","year":"2024","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2025.120218_b0075","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1021\/bi051608t","article-title":"The pathway by which the tetrameric protein transthyretin dissociates","volume":"44","author":"Foss","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2025.120218_b0080","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1021\/bi500430w","article-title":"A complex equilibrium among partially unfolded conformations in monomeric transthyretin","volume":"53","author":"Conti","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2025.120218_b0085","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis","volume":"47","author":"Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2025.120218_b0090","first-page":"324","article-title":"Chinese expert consensus on the diagnosis and treatment of transthyretin cardiac amyoidosis","volume":"49","author":"Heart Failure Group of Chinese Society of Cardiology","year":"2021","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cca.2025.120218_b0095","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2025.120218_b0100","unstructured":"CLSI, Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline\u2014Third Edition, EP28-A3. (2010), https:\/\/clsi. org\/standards\/products\/method-evaluation\/documents\/ep28\/."},{"key":"10.1016\/j.cca.2025.120218_b0105","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.2007.12.9437","article-title":"Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial","volume":"26","author":"Dowsett","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.cca.2025.120218_b0110","article-title":"Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding","volume":"301","author":"Ayaweera","year":"2024","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.cca.2025.120218_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10741-023-10339-w","article-title":"Sex differences in transthyretin cardiac amyloidosis","volume":"29","author":"Aimo","year":"2024","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.cca.2025.120218_b0120","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1007\/s00018-021-03899-3","article-title":"The role of transthyretin in cell biology: impact on human pathophysiology","volume":"78","author":"Magalh\u00e3es","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"10.1016\/j.cca.2025.120218_b0125","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/cells10071768","article-title":"Transthyretin: from structural stability to osteoarticular and cardiovascular diseases","volume":"10","author":"Wieczorek","year":"2021","journal-title":"Cells."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812500097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989812500097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:05:26Z","timestamp":1762113926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989812500097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":25,"alternative-id":["S000989812500097X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120218","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The establishment of specific reference intervals for serum transthyretin tetramer, misfolded proteins, and protein misfolding rate and its application in evaluating transthyretin amyloidosis patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120218"}}